Nachrichten zur Iovance Biotherapeutics Inc. Aktie

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jul 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics down 10% on $150M stock offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance (IOVA) Gets Positive FDA Feedback on Lung Cancer Drug

Based on feedback from the FDA, Iovances (IOVA) ongoing mid-stage study on LN-145 in NSCLC could support approval under the…

Why Iovance Biotherapeutics Stock Is Dropping Tuesday

The company is doing a $150 million public stock offering....…

Iovance Biotherapeutics Shares Fall Premarket After Stock Offering >IOVA

Iovance Biotherapeutics Shares Fall Premarket After Stock Offering >IOVA...…

Biggest stock movers today: Iovance Biotherapeutics and Viridian Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

WD-40 shares climb after earnings top estimates, Iovance stock slumps on offering, and other stocks on the move

WD-40, Iovance Biotherapeutics and ADT are stocks on the move....…

Amazon, Microsoft, WD-40, Iovance Biotherapeutics, and More Stock Market Movers

Amazon shares rise as Prime Day, the online retailer's shopping extravaganza, kicks off, Microsoft makes further job cuts, and WD-40's…

Iovance Biotherapeutics stock dips on pricing $150M stock offering

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $150 Million of Common Stock

SAN CARLOS, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology…

Fisker, Iovance Biotherapeutics Lead Gains — Tesla Dips: Top 5 Trending Stocks Today

Stocks to Watch: EzFill, Better Therapeutics, Iovance Biotherapeutics, E2open

Stocks to Watch: EzFill, Better Therapeutics, Iovance Biotherapeutics, E2open...…

Iovance Biotherapeutics Shares Fall After News of Planned Public Offering

Iovance Biotherapeutics Shares Fall After News of Planned Public Offering...…

Iovance Biotherapeutics proposes $150M stock offering, shares fall 9% after hours

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

SAN CARLOS, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology…

FMC, Outset Medical fall; Iovance, Helen of Troy rise, Monday, 7/10/2023

Stocks that are trading heavily or have substantial price changes Monday: FMC, Outset Medical fall; Iovance, Helen of Troy rise...…

Iovance Biotherapeutics Shares Rise 12% After Positive Lung Cancer Therapy Trial Data

Iovance Biotherapeutics Shares Rise 12% After Positive Lung Cancer Therapy Trial Data...…

Iovance receives FDA feedback on lung cancer candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer

Positive FDA Feedback Supports IOV-LUN-202 Trial Design for Accelerated Approval of TIL Therapy in Post-Anti-PD-1 Advanced Non-Small Cell Lung Cancer (NSCLC)...…

Barclays bullish on Biomea, Replimune, Syndax, Iovance for 2H 2023

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance (IOVA) Updates on Combo Drug in Advanced Melanoma Study

Iovance (IOVA) announces randomizing the first patient in the TILVANCE-301 study evaluating the safety and efficacy of its lifileucel/Keytruda combo…

Iovance Biotherapeutics Announces First Patient Randomized in Phase 3 TILVANCE-301 Trial in Frontline Advanced Melanoma

Global Trial of Iovance TIL Therapy Lifileucel in Combination with Pembrolizumab Global Trial of Iovance TIL Therapy Lifileucel in Combination…

Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference

SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company…

Why Is Iovance Biotherapeutics (IOVA) Up 7.9% Since Last Earnings Report?

Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K/A IOVANCE BIOTHERAPEUTICS, For: May 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Shares of Iovance Biotherapeutics Jumped Tuesday

The company received approval for a biologics license application for an advanced melanoma therapy....…

Iovance rises as Wall Street reacts to FDA priority review for melanoma drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Stocks to Watch: Iovance Biotherapeutics, Lexicon Pharmaceuticals

Stocks to Watch: Iovance Biotherapeutics, Lexicon Pharmaceuticals...…

Iovance Shares Shares Get After-Hours Boost From FDA Approval

Iovance Shares Shares Get After-Hours Boost From FDA Approval...…

Iovance up 15% on FDA acceptance of lifileucel application for melanoma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023...…

dpa-AFX ProFeed